;PMID: 8633516
;source_file_1410.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..41] = [t:0..41]
;1)sentence:[e:46..155] = [t:46..155]
;2)section:[e:159..242] = [t:159..242]
;3)section:[e:246..329] = [t:246..329]
;4)sentence:[e:333..485] = [t:333..485]
;5)sentence:[e:487..621] = [t:487..621]
;6)sentence:[e:622..726] = [t:622..726]
;7)sentence:[e:727..976] = [t:727..976]
;8)sentence:[e:977..1087] = [t:977..1087]
;9)sentence:[e:1088..1207] = [t:1088..1207]
;10)sentence:[e:1208..1321] = [t:1208..1321]
;11)section:[e:1325..1343] = [t:1325..1343]
;12)section:[e:1345..1351] = [t:1345..1351]
;13)section:[e:1353..1377] = [t:1353..1377]
;14)section:[e:1381..1425] = [t:1381..1425]

;section 0 Span:0..41
;Am J Gastroenterol  1996 Mar;91(3):587-91
(SEC
  (FRAG (NNP:[0..2] Am) (NNP:[3..4] J) (NNP:[5..18] Gastroenterol)
        (CD:[20..24] 1996) (CD:[25..32] Mar;91-LRB-) (CD:[32..33] 3)
        (-RRB-:[33..34] -RRB-) (CD:[34..38] :587) (HYPH:[38..39] -)
        (CD:[39..41] 91)))

;sentence 1 Span:46..155
;K-ras mutation in a tubular adenoma originating at an ileostomy in a familial
; adenomatous polyposis patient.
;[46..51]:gene-rna:"K-ras"
;[66..81]:malignancy:"tubular adenoma"
;[115..146]:malignancy:"familial  adenomatous polyposis"
(SENT
  (NP-HLN
    (NP (NN:[46..51] K-ras) (NN:[52..60] mutation))
    (PP-LOC (IN:[61..63] in)
      (NP
        (NP (DT:[64..65] a)
           (JJ:[66..73] tubular) (NN:[74..81] adenoma))
        (VP (VBG:[82..93] originating)
          (PP-LOC (IN:[94..96] at)
            (NP
              (NP (DT:[97..99] an) (NN:[100..109] ileostomy))
              (PP-LOC (IN:[110..112] in)
                (NP (DT:[113..114] a)
                   (JJ:[115..123] familial)
                  (NML (JJ:[125..136] adenomatous) (NN:[137..146] polyposis))
                  (NN:[147..154] patient))))))))
    (.:[154..155] .)))

;section 2 Span:159..242
;Herring JA, Hall CC, Johnson JA, Poole GV, Subramony C, Suvarna-Gurram V,
;Hall  TJ.
(SEC
  (FRAG (NNP:[159..166] Herring) (NNP:[167..169] JA) (,:[169..170] ,)
        (NNP:[171..175] Hall) (NNP:[176..178] CC) (,:[178..179] ,)
        (NNP:[180..187] Johnson) (NNP:[188..190] JA) (,:[190..191] ,)
        (NNP:[192..197] Poole) (NNP:[198..200] GV) (,:[200..201] ,)
        (NNP:[202..211] Subramony) (NNP:[212..213] C) (,:[213..214] ,)
        (NNP:[215..222] Suvarna) (HYPH:[222..223] -) (NNP:[223..229] Gurram)
        (NNP:[230..231] V) (,:[231..232] ,) (NNP:[233..237] Hall)
        (NNP:[239..242] TJ.)))

;section 3 Span:246..329
;Department of Biochemistry, University of Mississippi Medical Center, Jackson
; USA.
(SEC
  (FRAG (NNP:[246..256] Department) (IN:[257..259] of)
        (NNP:[260..272] Biochemistry) (,:[272..273] ,)
        (NNP:[274..284] University) (IN:[285..287] of)
        (NNP:[288..299] Mississippi) (NNP:[300..307] Medical)
        (NNP:[308..314] Center) (,:[314..315] ,) (NNP:[316..323] Jackson)
        (NNP:[325..328] USA) (.:[328..329] .)))

;sentence 4 Span:333..485
;Genetic alterations in a tubular adenoma with severe dysplasia arising in a 
;Brooke ileostomy of a familial adenomatous polyposis patient were analyzed.
;[358..373]:malignancy:"tubular adenoma"
;[386..395]:malignancy:"dysplasia"
;[432..462]:malignancy:"familial adenomatous polyposis"
(SENT
  (S
    (NP-SBJ-1
      (NP (JJ:[333..340] Genetic) (NNS:[341..352] alterations))
      (PP-LOC (IN:[353..355] in)
        (NP
          (NP
            (NP (DT:[356..357] a)
               (JJ:[358..365] tubular) (NN:[366..373] adenoma))
            (PP (IN:[374..378] with)
              (NP (JJ:[379..385] severe) (NN:[386..395] dysplasia))))
          (VP (VBG:[396..403] arising)
            (PP-LOC (IN:[404..406] in)
              (NP
                (NP (DT:[407..408] a) (NNP:[410..416] Brooke)
                    (NN:[417..426] ileostomy))
                (PP (IN:[427..429] of)
                  (NP (DT:[430..431] a)
                     (JJ:[432..440] familial)
                    (NML (JJ:[441..452] adenomatous) (NN:[453..462] polyposis))
                    (NN:[463..470] patient)))))))))
    (VP (VBD:[471..475] were)
      (VP (VBN:[476..484] analyzed)
        (NP-1 (-NONE-:[484..484] *))))
    (.:[484..485] .)))

;sentence 5 Span:487..621
;Clinical and morphological characteristics suggest that ileal mucosa
;progressed  to colonic metaplasia and then to dysplastic adenoma.
;[571..589]:malignancy:"colonic metaplasia"
;[602..620]:malignancy:"dysplastic adenoma"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[487..495] Clinical)
        (NML-1 (-NONE-:[495..495] *P*)))
      (CC:[496..499] and)
      (NP (JJ:[500..513] morphological)
        (NML-1 (NNS:[514..529] characteristics))))
    (VP (VBP:[530..537] suggest)
      (SBAR (IN:[538..542] that)
        (S
          (NP-SBJ (JJ:[543..548] ileal) (NN:[549..555] mucosa))
          (VP (VBD:[556..566] progressed)
            (PP
              (PP (TO:[568..570] to)
                (NP (JJ:[571..578] colonic) (NN:[579..589] metaplasia)))
              (CONJP (CC:[590..593] and) (RB:[594..598] then))
              (PP (TO:[599..601] to)
                (NP (JJ:[602..612] dysplastic) (NN:[613..620] adenoma))))))))
    (.:[620..621] .)))

;sentence 6 Span:622..726
;Such changes at ileostomy  sites are rare, and little is known about the
;associated genetic alterations.
(SENT
  (S
    (S
      (NP-SBJ
        (NP (JJ:[622..626] Such) (NNS:[627..634] changes))
        (PP-LOC (IN:[635..637] at)
          (NP (NN:[638..647] ileostomy) (NNS:[649..654] sites))))
      (VP (VBP:[655..658] are)
        (ADJP-PRD (JJ:[659..663] rare))))
    (,:[663..664] ,) (CC:[665..668] and)
    (S
      (NP-SBJ-1 (JJ:[669..675] little))
      (VP (VBZ:[676..678] is)
        (VP (VBN:[679..684] known)
          (NP-1 (-NONE-:[684..684] *))
          (PP (IN:[685..690] about)
            (NP (DT:[691..694] the) (VBN:[695..705] associated)
                (JJ:[706..713] genetic) (NNS:[714..725] alterations))))))
    (.:[725..726] .)))

;sentence 7 Span:727..976
;To  determine whether metaplastic epithelium progression to adenoma in the
;ileum is  subject to the same mutations identified in colon carcinogenesis,
;we evaluated  somatic genetic alterations associated with sporadic colorectal
;cancer  development.
;[787..807]:malignancy:"adenoma in the ileum"
;[832..841]:variation-event:"mutations"
;[936..962]:malignancy:"sporadic colorectal cancer"
(SENT
  (S
    (S-PRP
      (NP-SBJ (-NONE-:[727..727] *))
      (VP (TO:[727..729] To)
        (VP (VB:[731..740] determine)
          (SBAR (IN:[741..748] whether)
            (S
              (NP-SBJ
                (NP (JJ:[749..760] metaplastic) (NN:[761..771] epithelium)
                    (NN:[772..783] progression))
                (PP (TO:[784..786] to)
                  (NP (NN:[787..794] adenoma)))
                (PP-LOC (IN:[795..797] in)
                  (NP (DT:[798..801] the) (NN:[802..807] ileum))))
              (VP (VBZ:[808..810] is)
                (ADJP-PRD (JJ:[812..819] subject)
                  (PP (TO:[820..822] to)
                    (NP
                      (NP (DT:[823..826] the) (JJ:[827..831] same)
                          (NNS:[832..841] mutations))
                      (VP (VBN:[842..852] identified)
                        (NP (-NONE-:[852..852] *))
                        (PP (IN:[853..855] in)
                          (NP (NN:[856..861] colon)
                              (NN:[862..876] carcinogenesis)))))))))))))
    (,:[876..877] ,)
    (NP-SBJ (PRP:[878..880] we))
    (VP (VBD:[881..890] evaluated)
      (NP
        (NP (JJ:[892..899] somatic) (JJ:[900..907] genetic)
            (NNS:[908..919] alterations))
        (VP (VBN:[920..930] associated)
          (NP (-NONE-:[930..930] *))
          (PP-CLR (IN:[931..935] with)
            (NP
               (JJ:[936..944] sporadic) (JJ:[945..955] colorectal)
               (NN:[956..962] cancer)
              (NN:[964..975] development))))))
    (.:[975..976] .)))

;sentence 8 Span:977..1087
;Sequences examined included mutation cluster regions of the p53  tumor
;suppressor gene and the k-ras oncogene.
;[1037..1040]:gene-rna:"p53"
;[1072..1077]:gene-rna:"k-ras"
(SENT
  (S
    (NP-SBJ
      (NP (NNS:[977..986] Sequences))
      (VP (VBN:[987..995] examined)
        (NP (-NONE-:[995..995] *))))
    (VP (VBD:[996..1004] included)
      (NP
        (NP (NN:[1005..1013] mutation) (NN:[1014..1021] cluster)
            (NNS:[1022..1029] regions))
        (PP (IN:[1030..1032] of)
          (NP
            (NP (DT:[1033..1036] the) (NN:[1037..1040] p53)
              (NML (NN:[1042..1047] tumor) (NN:[1048..1058] suppressor))
              (NN:[1059..1063] gene))
            (CC:[1064..1067] and)
            (NP (DT:[1068..1071] the) (NN:[1072..1077] k-ras)
                (NN:[1078..1086] oncogene))))))
    (.:[1086..1087] .)))

;sentence 9 Span:1088..1207
;Using polymerase chain reaction  and DNA sequencing, we identified a point
;mutation at codon 12 of the K-ras  oncogene.
;[1094..1104]:gene-protein:"polymerase"
;[1157..1171]:variation-type:"point mutation"
;[1175..1183]:variation-location:"codon 12"
;[1191..1196]:gene-rna:"K-ras"
(SENT
  (S
    (S-MNR
      (NP-SBJ (-NONE-:[1088..1088] *))
      (VP (VBG:[1088..1093] Using)
        (NP
          (NP (NN:[1094..1104] polymerase) (NN:[1105..1110] chain)
              (NN:[1111..1119] reaction))
          (CC:[1121..1124] and)
          (NP (NN:[1125..1128] DNA) (NN:[1129..1139] sequencing)))))
    (,:[1139..1140] ,)
    (NP-SBJ (PRP:[1141..1143] we))
    (VP (VBD:[1144..1154] identified)
      (NP (DT:[1155..1156] a)
         (NN:[1157..1162] point) (NN:[1163..1171] mutation))
      (PP-LOC (IN:[1172..1174] at)
        (NP
          (NP (NN:[1175..1180] codon) (CD:[1181..1183] 12))
          (PP (IN:[1184..1186] of)
            (NP (DT:[1187..1190] the) (NN:[1191..1196] K-ras)
                (NN:[1198..1206] oncogene))))))
    (.:[1206..1207] .)))

;sentence 10 Span:1208..1321
;To our knowledge, this is the first report of a ras mutation occurring  in a
;tumor originating from ileal mucosa.
;[1256..1259]:gene-rna:"ras"
;[1285..1290]:malignancy:"tumor"
(SENT
  (S
    (PP (TO:[1208..1210] To)
      (NP (PRP$:[1211..1214] our) (NN:[1215..1224] knowledge)))
    (,:[1224..1225] ,)
    (NP-SBJ (DT:[1226..1230] this))
    (VP (VBZ:[1231..1233] is)
      (NP-PRD
        (NP (DT:[1234..1237] the) (JJ:[1238..1243] first)
            (NN:[1244..1250] report))
        (PP (IN:[1251..1253] of)
          (S-NOM
            (NP-SBJ (DT:[1254..1255] a) (NN:[1256..1259] ras)
                    (NN:[1260..1268] mutation))
            (VP (VBG:[1269..1278] occurring)
              (PP-LOC (IN:[1280..1282] in)
                (NP
                  (NP (DT:[1283..1284] a) (NN:[1285..1290] tumor))
                  (VP (VBG:[1291..1302] originating)
                    (PP (IN:[1303..1307] from)
                      (NP (JJ:[1308..1313] ileal) (NN:[1314..1320] mucosa)))))))))))
    (.:[1320..1321] .)))

;section 11 Span:1325..1343
;Publication Types:
(SEC
  (FRAG (NNP:[1325..1336] Publication) (NNP:[1337..1342] Types)
        (NNP:[1342..1343] :)))

;section 12 Span:1345..1351
;Review
(SEC
  (FRAG (NNP:[1345..1351] Review)))

;section 13 Span:1353..1377
;Review of Reported Cases
(SEC
  (FRAG (NNP:[1353..1359] Review) (IN:[1360..1362] of)
        (NNP:[1363..1371] Reported) (NNP:[1372..1377] Cases)))

;section 14 Span:1381..1425
;PMID: 8633516 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1381..1385] PMID) (::[1385..1386] :) (CD:[1387..1394] 8633516)
        (IN:[1395..1396] -LSB-) (NNP:[1396..1402] PubMed) (HYPH:[1403..1404] -)
        (JJ:[1405..1412] indexed) (IN:[1413..1416] for)
        (NNP:[1417..1425] MEDLINE-RSB-)))
